KRONOS BIO INC. - COM

0,9500

29-ноября-24 13:45:00

15 мин. задержка

Акции

-0,0101

-1,05%

Сегодняшний диапазон

0,9353 - 1,0000

ISIN

N/A

Источник

NASDAQ

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

27 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement

25 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate

18 дек 2023 16:06:03 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

04 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference

27 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results

13 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study

02 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting

02 ноя 2023 12:00:00 Источник Nasdaq GlobeNewswire
Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting

27 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC

13 окт 2023 12:30:00 Источник Nasdaq GlobeNewswire
Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13

04 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development

17 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire
Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial Results

08 авг 2023 16:05:03 Источник Nasdaq GlobeNewswire
Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance

06 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Participation in Upcoming Investor Conferences

01 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results

10 май 2023 16:05:02 Источник Nasdaq GlobeNewswire
Kronos Bio Appoints Roger Dansey, M.D., to Board of Directors

24 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Changes to Board of Directors

11 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results

15 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
Kronos Bio Announces Participation in 43rd Annual Cowen Health Care Conference

28 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.